Corpus GrippeAllemagneV3

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Estimation of influenza-attributable medically attended acute respiratory illness by influenza type/subtype and age, Germany, 2001/02-2014/15.

Identifieur interne : 000058 ( Main/Exploration ); précédent : 000057; suivant : 000059

Estimation of influenza-attributable medically attended acute respiratory illness by influenza type/subtype and age, Germany, 2001/02-2014/15.

Auteurs : Matthias An Der Heiden [Allemagne] ; Udo Buchholz [Allemagne]

Source :

RBID : pubmed:27754611

Descripteurs français

English descriptors

Abstract

BACKGROUND

The total burden of influenza in primary care is difficult to assess. The case definition of medically attended "acute respiratory infection" (MAARI) in the German physician sentinel is sensitive; however, it requires modelling techniques to derive estimates of disease attributable to influenza. We aimed to examine the impact of type/subtype and age.

METHODS

Data on MAARI and virological results of respiratory samples (virological sentinel) were available from 2001/02 until 2014/15. We constructed a generalized additive regression model for the periodic baseline and the secular trend. The weekly number of influenza-positive samples represented influenza activity. In a second step, we distributed the estimated influenza-attributable MAARI (iMAARI) according to the distribution of types/subtypes in the virological sentinel.

RESULTS

Season-specific iMAARI ranged from 0.7% to 8.9% of the population. Seasons with the strongest impact were dominated by A(H3), and iMAARI attack rate of the pandemic 2009 (A(H1)pdm09) was 4.9%. Regularly the two child age groups (0-4 and 5-14 years old) had the highest iMAARI attack rates reaching frequently levels up to 15%-20%. Influenza B affected the age group of 5- to 14-year-old children substantially more than any other age group. Sensitivity analyses demonstrated both comparability and stability of the model.

CONCLUSION

We constructed a model that is well suited to estimate the substantial impact of influenza on the primary care sector. A(H3) causes overall the greatest number of iMAARI, and influenza B has the greatest impact on school-age children. The model may incorporate time series of other pathogens as they become available.


DOI: 10.1111/irv.12434
PubMed: 27754611


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Estimation of influenza-attributable medically attended acute respiratory illness by influenza type/subtype and age, Germany, 2001/02-2014/15.</title>
<author>
<name sortKey="An Der Heiden, Matthias" sort="An Der Heiden, Matthias" uniqKey="An Der Heiden M" first="Matthias" last="An Der Heiden">Matthias An Der Heiden</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin</wicri:regionArea>
<placeName>
<region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Buchholz, Udo" sort="Buchholz, Udo" uniqKey="Buchholz U" first="Udo" last="Buchholz">Udo Buchholz</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin</wicri:regionArea>
<placeName>
<region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:27754611</idno>
<idno type="pmid">27754611</idno>
<idno type="doi">10.1111/irv.12434</idno>
<idno type="wicri:Area/Main/Corpus">000074</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000074</idno>
<idno type="wicri:Area/Main/Curation">000074</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000074</idno>
<idno type="wicri:Area/Main/Exploration">000074</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Estimation of influenza-attributable medically attended acute respiratory illness by influenza type/subtype and age, Germany, 2001/02-2014/15.</title>
<author>
<name sortKey="An Der Heiden, Matthias" sort="An Der Heiden, Matthias" uniqKey="An Der Heiden M" first="Matthias" last="An Der Heiden">Matthias An Der Heiden</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin</wicri:regionArea>
<placeName>
<region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Buchholz, Udo" sort="Buchholz, Udo" uniqKey="Buchholz U" first="Udo" last="Buchholz">Udo Buchholz</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin</wicri:regionArea>
<placeName>
<region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Influenza and other respiratory viruses</title>
<idno type="eISSN">1750-2659</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Acute Disease (epidemiology)</term>
<term>Adolescent</term>
<term>Age Factors</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Cost of Illness</term>
<term>Female</term>
<term>Germany (epidemiology)</term>
<term>Humans</term>
<term>Incidence</term>
<term>Infant</term>
<term>Infant, Newborn</term>
<term>Influenza A Virus, H1N1 Subtype (genetics)</term>
<term>Influenza A Virus, H1N1 Subtype (isolation & purification)</term>
<term>Influenza A Virus, H3N2 Subtype (genetics)</term>
<term>Influenza A Virus, H3N2 Subtype (isolation & purification)</term>
<term>Influenza, Human (diagnostic imaging)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (virology)</term>
<term>Male</term>
<term>Models, Theoretical</term>
<term>Pandemics</term>
<term>Respiratory Tract Infections (diagnosis)</term>
<term>Respiratory Tract Infections (epidemiology)</term>
<term>Respiratory Tract Infections (virology)</term>
<term>Seasons</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent</term>
<term>Allemagne (épidémiologie)</term>
<term>Coût de la maladie</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Facteurs de l'âge</term>
<term>Femelle</term>
<term>Grippe humaine (imagerie diagnostique)</term>
<term>Grippe humaine (virologie)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains</term>
<term>Incidence</term>
<term>Infections de l'appareil respiratoire (diagnostic)</term>
<term>Infections de l'appareil respiratoire (virologie)</term>
<term>Infections de l'appareil respiratoire (épidémiologie)</term>
<term>Maladie aigüe (épidémiologie)</term>
<term>Modèles théoriques</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Nouveau-né</term>
<term>Pandémies</term>
<term>Saisons</term>
<term>Sous-type H1N1 du virus de la grippe A (génétique)</term>
<term>Sous-type H1N1 du virus de la grippe A (isolement et purification)</term>
<term>Sous-type H3N2 du virus de la grippe A (génétique)</term>
<term>Sous-type H3N2 du virus de la grippe A (isolement et purification)</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Respiratory Tract Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Infections de l'appareil respiratoire</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Acute Disease</term>
<term>Germany</term>
<term>Influenza, Human</term>
<term>Respiratory Tract Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza A Virus, H3N2 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Sous-type H3N2 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr">
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en">
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza A Virus, H3N2 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr">
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Sous-type H3N2 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Grippe humaine</term>
<term>Infections de l'appareil respiratoire</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Influenza, Human</term>
<term>Respiratory Tract Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Allemagne</term>
<term>Grippe humaine</term>
<term>Infections de l'appareil respiratoire</term>
<term>Maladie aigüe</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Age Factors</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Cost of Illness</term>
<term>Female</term>
<term>Humans</term>
<term>Incidence</term>
<term>Infant</term>
<term>Infant, Newborn</term>
<term>Male</term>
<term>Models, Theoretical</term>
<term>Pandemics</term>
<term>Seasons</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Coût de la maladie</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Facteurs de l'âge</term>
<term>Femelle</term>
<term>Humains</term>
<term>Incidence</term>
<term>Modèles théoriques</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Nouveau-né</term>
<term>Pandémies</term>
<term>Saisons</term>
<term>Vaccination</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>BACKGROUND</b>
</p>
<p>The total burden of influenza in primary care is difficult to assess. The case definition of medically attended "acute respiratory infection" (MAARI) in the German physician sentinel is sensitive; however, it requires modelling techniques to derive estimates of disease attributable to influenza. We aimed to examine the impact of type/subtype and age.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>METHODS</b>
</p>
<p>Data on MAARI and virological results of respiratory samples (virological sentinel) were available from 2001/02 until 2014/15. We constructed a generalized additive regression model for the periodic baseline and the secular trend. The weekly number of influenza-positive samples represented influenza activity. In a second step, we distributed the estimated influenza-attributable MAARI (iMAARI) according to the distribution of types/subtypes in the virological sentinel.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>RESULTS</b>
</p>
<p>Season-specific iMAARI ranged from 0.7% to 8.9% of the population. Seasons with the strongest impact were dominated by A(H3), and iMAARI attack rate of the pandemic 2009 (A(H1)pdm09) was 4.9%. Regularly the two child age groups (0-4 and 5-14 years old) had the highest iMAARI attack rates reaching frequently levels up to 15%-20%. Influenza B affected the age group of 5- to 14-year-old children substantially more than any other age group. Sensitivity analyses demonstrated both comparability and stability of the model.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>CONCLUSION</b>
</p>
<p>We constructed a model that is well suited to estimate the substantial impact of influenza on the primary care sector. A(H3) causes overall the greatest number of iMAARI, and influenza B has the greatest impact on school-age children. The model may incorporate time series of other pathogens as they become available.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">27754611</PMID>
<DateCompleted>
<Year>2017</Year>
<Month>09</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>04</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1750-2659</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>11</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2017</Year>
<Month>03</Month>
</PubDate>
</JournalIssue>
<Title>Influenza and other respiratory viruses</Title>
<ISOAbbreviation>Influenza Other Respir Viruses</ISOAbbreviation>
</Journal>
<ArticleTitle>Estimation of influenza-attributable medically attended acute respiratory illness by influenza type/subtype and age, Germany, 2001/02-2014/15.</ArticleTitle>
<Pagination>
<MedlinePgn>110-121</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/irv.12434</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND">The total burden of influenza in primary care is difficult to assess. The case definition of medically attended "acute respiratory infection" (MAARI) in the German physician sentinel is sensitive; however, it requires modelling techniques to derive estimates of disease attributable to influenza. We aimed to examine the impact of type/subtype and age.</AbstractText>
<AbstractText Label="METHODS">Data on MAARI and virological results of respiratory samples (virological sentinel) were available from 2001/02 until 2014/15. We constructed a generalized additive regression model for the periodic baseline and the secular trend. The weekly number of influenza-positive samples represented influenza activity. In a second step, we distributed the estimated influenza-attributable MAARI (iMAARI) according to the distribution of types/subtypes in the virological sentinel.</AbstractText>
<AbstractText Label="RESULTS">Season-specific iMAARI ranged from 0.7% to 8.9% of the population. Seasons with the strongest impact were dominated by A(H3), and iMAARI attack rate of the pandemic 2009 (A(H1)pdm09) was 4.9%. Regularly the two child age groups (0-4 and 5-14 years old) had the highest iMAARI attack rates reaching frequently levels up to 15%-20%. Influenza B affected the age group of 5- to 14-year-old children substantially more than any other age group. Sensitivity analyses demonstrated both comparability and stability of the model.</AbstractText>
<AbstractText Label="CONCLUSION">We constructed a model that is well suited to estimate the substantial impact of influenza on the primary care sector. A(H3) causes overall the greatest number of iMAARI, and influenza B has the greatest impact on school-age children. The model may incorporate time series of other pathogens as they become available.</AbstractText>
<CopyrightInformation>© 2016 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>An der Heiden</LastName>
<ForeName>Matthias</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Buchholz</LastName>
<ForeName>Udo</ForeName>
<Initials>U</Initials>
<AffiliationInfo>
<Affiliation>Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2016</Year>
<Month>11</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Influenza Other Respir Viruses</MedlineTA>
<NlmUniqueID>101304007</NlmUniqueID>
<ISSNLinking>1750-2640</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017281" MajorTopicYN="N">Cost of Illness</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005858" MajorTopicYN="N">Germany</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053122" MajorTopicYN="N">Influenza A Virus, H3N2 Subtype</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008962" MajorTopicYN="N">Models, Theoretical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">Germany</Keyword>
<Keyword MajorTopicYN="Y">burden of disease</Keyword>
<Keyword MajorTopicYN="Y">generalised additive model</Keyword>
<Keyword MajorTopicYN="Y">influenza</Keyword>
<Keyword MajorTopicYN="Y">influenza type/subtype</Keyword>
<Keyword MajorTopicYN="Y">medically attended acute respiratory illness</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="accepted">
<Year>2016</Year>
<Month>10</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>10</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>9</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>10</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">27754611</ArticleId>
<ArticleId IdType="doi">10.1111/irv.12434</ArticleId>
<ArticleId IdType="pmc">PMC5304576</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Euro Surveill. 2006;11(5):111-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16757850</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2014 Feb 06;19(5):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24524235</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2015 Jun 04;20(22):21145</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26062645</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatrics. 2013 Feb;131(2):207-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23296444</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2013 Apr 11;18(15):20451</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23594577</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 1985 Jun;121(6):811-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">4014174</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2012;7(12):e51653</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23240050</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2013 Jul 16;8(7):e64593</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23874380</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Epidemiol Infect. 2000 Apr;124(2):245-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10813150</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Vaccine Immunol. 2011 Mar;18(3):469-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21209157</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect. 2014 Apr;68(4):363-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24291062</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Respir Med. 2015 Sep;3(9):709-718</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26300111</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Pediatr. 2010 Aug;169(8):997-1008</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20229049</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2009 Sep 15;49(6):861-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19663691</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2012 Oct 1;206(7):1078-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22837493</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Epidemiol. 2003;18(8):751-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12974549</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2010 May 15;201(10):1509-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20377412</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 2008 Apr 1;167(7):775-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18230677</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Respir Med. 2014 Jun;2(6):445-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24717637</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Med. 2011 Jul;8(7):e1001051</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21750666</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Allemagne</li>
</country>
<region>
<li>Berlin</li>
</region>
<settlement>
<li>Berlin</li>
</settlement>
</list>
<tree>
<country name="Allemagne">
<region name="Berlin">
<name sortKey="An Der Heiden, Matthias" sort="An Der Heiden, Matthias" uniqKey="An Der Heiden M" first="Matthias" last="An Der Heiden">Matthias An Der Heiden</name>
</region>
<name sortKey="Buchholz, Udo" sort="Buchholz, Udo" uniqKey="Buchholz U" first="Udo" last="Buchholz">Udo Buchholz</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeAllemagneV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000058 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000058 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeAllemagneV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:27754611
   |texte=   Estimation of influenza-attributable medically attended acute respiratory illness by influenza type/subtype and age, Germany, 2001/02-2014/15.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:27754611" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeAllemagneV3 

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Tue Jul 7 11:47:10 2020. Site generation: Sat Sep 26 09:55:33 2020